New Rules Dealing with Conflicts of Interest in Public Health Service Funded Research BRAFF


Published on

Research Administration

  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

New Rules Dealing with Conflicts of Interest in Public Health Service Funded Research BRAFF

  1. 1. 18th HMORN Annual Conference May 1, 2012 Seattle, Washington Jeffrey P. Braff, DrPHDirector—Human Research Protections Kaiser Foundation Research Institute
  2. 2.  The new regulations ◦ Why ◦ What are the major differences between the current regulations and the new ones  What this means for you as an institution  What this means for you as a researcher ◦ What these differences represent What does an institution need to do to comply with the new rules ◦ Implementation issues that you’re likely facing
  3. 3. Responsibility of Applicants for Promoting Objectivity in Research for which PHS Funding is Sought-42 CFR Part 50 Subpart F Advance Notice – May 8, 2009 Proposed Rule – May 21, 2010 Final Rule Published August 25, 2011 in the Federal Register ◦ ◦ Compliance Date: August 24, 2012 or when the new COI policy is put on your institution’s publicly-accessible website, if earlier. 3
  4. 4.  Egregious violations of current regulations and institutional policies at large academic medical centers (Harvard, Emory, Penn) Heightened visibility and action from Congressional investigations (Sen. Grassley) Desire for transparency (NIH: Collins, Rockey) “The National Institutes of Health must ensure that the research it funds on the behalf of US taxpayers is scientifically rigorous and free of bias. ... [M]ore must be done to retain, and in some instances regain, public trust in the biomedical and behavioral research enterprise.” Managing financial conflict of interest in biomedical research. JAMA 2010;303(23). 4
  5. 5. 1995 Regulations 2011 RegulationsSFI Disclosure Requirements $10,000 de minimis $5,000 de minimis Equity >5% Any non-publicly traded Prospective equity Research-related Retrospective Related to institutional dutiesTravel Reimbursements No explicit mention Any reimbursed travel except government or funded by an institution of higher learning must be disclosedPublic Accessibility None Institutional policy FCOIs for PHS-sponsored research held by senior/key personnelTraining None RequiredInstitutional Review None Retrospective review- mitigation plan 5
  6. 6.  The new regulations remove investigator personal discretion about what possibly conflicting financial interests related to their research they must report.   The new regulations essentially require that institutions collect from investigators an annual disclosure of all financial interests held by that investigator that are related to any of the investigator’s “institutional responsibilities,” including clinical work, research, committee service, etc.   The institution then makes the determination whether any of these reported financial interests may represent a conflict of interest in the investigator’s specific proposed research, and must take appropriate action to manage any perceived conflicts.  6
  7. 7. Remuneration or Equity Does it meet the disclosure threshold? Is it a Significant Financial Interest? Is it related to research? This is a potential Financial Conflict of InterestDoes it affect the design, conduct, or reporting of the research? This is a Financial Conflict of Interest Develop a Management Plan Report the FCOI and Details to the NIH Make the information publicly available Thanks to Heather Pierce, JD American Association of Medical Colleges
  8. 8.  Informing, involving, and educating stakeholders Seeking approval of and promulgating the new regulations in a policy document Revising and developing procedures dealing with: ◦ Operations ◦ Training ◦ Infrastructure Learning from both the feds and other research institutions The landscape is still forming. NIH recently issued (March 21) new FAQs in response to requests from extramural awardees. 8
  9. 9.  Application of the same disclosure procedures (not reporting procedures) for federally-funded and non-federally-funded research. Identification of all investigators. Are they the same as “key personnel?” How do we assess the “relatedness” of reported financial interests to the nature of the research? What, if any, new infrastructure needs to be in place? The policy will be both outward- and inward- facing. This is new for some institutions. 9